Guatemala Specific Pollen Allergies Market – Industry Trends and Forecast to 2030

과테말라 특정 꽃가루 알레르기 시장 분석 및 규모

꽃가루 알레르기 반응의 높은 유병률, 알레르기에 대항하는 다양한 첨단 치료법을 갖춘 과테말라의 신약 승인 증가가 시장 성장을 주도하고 있습니다. 꽃가루 에어로알레르겐은 시장에 기회 역할을 하고 시장을 추진할 수 있습니다. 소아 인구에 미치는 영향은 환경 조건, 토양 사용의 변화, 다양한 꽃가루 계절, 치료 계획 측면에서 알레르기 전문의를 위한 연간 데이터에 따라 달라지며, 특정 꽃가루 알레르기 시장 성장을 주도할 것입니다.

Data Bridge Market Research는 2022년에 3억 9,369만 달러였던 과테말라 특정 꽃가루 알레르기 시장이 2030년까지 5억 8,951만 달러로 성장할 것으로 예상되며 예측 기간 동안 5.4%의 CAGR을 기록할 것으로 분석했습니다. 이는 시장 가치를 나타냅니다. "병원"은 병원에서 제품에 대한 수요가 증가함에 따라 특정 꽃가루 알레르기 시장의 최종 사용자 부문을 지배하고 있습니다. 시장 가치, 성장률, 세분화, 지리적 범위 및 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

과테말라 특정 꽃가루 알레르기 시장 범위 및 세분화

시장 정의

알레르기 질환은 신체에 미세먼지가 침입했을 때 신체가 면역 반응을 보이는 것입니다. 여기에는 꽃가루열, 음식 알레르기 , 아토피성 피부염 , 알레르기성 천식, 아나필락시스가 포함됩니다. 증상에는 눈 충혈, 가려운 발진, 재채기, 콧물, 호흡 곤란 또는 부기가 포함될 수 있습니다. 이러한 꽃가루(일반적으로 잡초 꽃가루)는 봄철에 대기에서 쉽게 발견되고 여름에는 잔디 꽃가루에서 발견됩니다. 알레르기 반응을 일으키는 대부분의 꽃가루는 나무, 잔디 및 잡초에서 나옵니다. 이 식물은 공기로 이동하는 작고 가볍고 건조한 꽃가루 알갱이를 만듭니다. 이것들은 어디에서나 쉽게 발견됩니다. 알레르겐을 완전히 피하는 것은 어렵기 때문에 알레르겐 면역 요법의 신속한 진단 및 신속한 치료 시작을 위해 원인 항원을 정확하게 식별하는 것이 중요합니다. 꽃가루 수는 일반적으로 공기 샘플링 장치로 측정합니다. 알레르기 질환의 유병률이 증가하고 있어 진단, 치료에 대한 통합적 방법과 환자들의 인식 제고가 필요합니다.

과테말라 특정 꽃가루 알레르기 시장 동향

운전자

• 알레르기 질환의 유병률 증가

알레르기가 있는 개인의 면역 체계가 물질에 과민하게 반응하는 것을 알레르기 반응이라고 합니다. 알레르겐이 신체에 들어오면 신체의 면역 체계가 알레르기 반응을 일으킵니다. 이 반응은 면역 체계가 일반적으로 무해한 물질을 공격할 때 발생할 수 있습니다. 이는 어느 연령대에서나 발생할 수 있지만, 면역 반응의 적절한 기능으로 인해 어린 나이에 더 자주 발생합니다.

다양한 개인이 꽃가루 알레르기 등 다양한 알레르겐에 알레르기 반응을 보일 수 있으며, 이는 일반적인 알레르기 반응 중 일부입니다. 알레르기 질환의 유병률이 증가하고 있으며, 이는 진단, 치료 및 환자에 대한 인식 제고를 위한 통합된 방법을 요구합니다. 많은 인구가 상당한 부담을 초래하는 알레르기 질환으로 고통받고 있습니다. 알레르기 사례가 증가함에 따라 치료에 대한 수요가 증가할 것으로 예상되며, 이는 예측 기간 동안 시장이 크게 성장할 것으로 이어집니다.

• 꽃가루 알레르기가 소아 인구에 미치는 영향

Pollen grains are commonly present in the atmosphere that cause various allergic diseases in North America. Pollen aeroallergens can act as opportunity for the market and propel the market in Mexico. The Impact on paediatric population depends on environmental conditions, changes in the use of soil, different pollen seasons, and annual data for allergists in terms of planning the treatment. The increase in forecasted pollen season longer than usual. The growth of the pollen market can be attributed to the increase in the tree pollen season in the country that elicits allergic reactions such as hay fever and rhinitis in the population which is anticipated to drive the market. Pollen in the atmosphere of Mexico City and its impact on the health of the paediatric population.

Hence, prevalence of pollen-induced allergic disease has been increasing with severe symptoms that can be one of the most common health issues affecting adults. Children are the largest age group affected. Coexistence of allergic diseases was found in 19.9%.This is expected to be one of the factors that act as a driver for the Guatemala specific pollen allergies market growth in the forecast period.

Opportunity

• Increase in the Environmental Pollution

Common air pollutants, such as ozone, sulphur dioxide, and nitrogen dioxide probably act more as irritants than as promoters of sensitization. These pollutants have been shown to be hazardous to adults and children with asthma. Recent studies suggest that prematurely born children are more sensitive to the respiratory effects of outdoor pollution.

Thus, pollution and allergies go hand-in-hand, worsening air and water pollution enables various heavy metals and non-metals an opportunity to come in close contact with skin and respiratory system thus causing allergies. This is increasing the demand for allergy medications.

The increasing air pollution along with water population is expected to increase the prevalence of respiratory and skin allergies, which is expected to increase the demand for the product used for allergy hence it is considered as opportunity for the market.

Restraint/Challenge

• Side Effects Associated with the Use of Drugs

Sometimes drugs have some kind of side effects or adverse effects among the population. The treatment of allergic response is a multi-drugs therapy, which has a greater chance of compatibility issue, which can cause the condition to get worse. Corticosteroids are known to lower the resistance to infection, which can make it harder to treat. It induced osteoporosis, steroids induced myopathy, and osteonecrosis are some of the disorders that are seen among those that use corticosteroids. Systemic administration of these drugs are known to increase the fasting blood glucose level, which make it vulnerable for the diabetic patients to use these therapies during allergic reaction, hence limiting the market growth.

Drowsiness, headache, dry mouth, throat, and/or nose, stomach pain, nausea, mucus thickening, and increased appetite/weight gain are some of the side effects induced in the patient taking anti-histaminic. Among all, the drug induced diseases are mostly seen among those that use corticosteroids therapy for longer period of time. These side effects of the drug is expected to limit the use of drugs hence act as restraint for the growth of the Guatemala specific pollen allergies market in the forecast period.

This specific pollen allergies market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the specific pollen allergies market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In July 2021, Prestige Consumer Healthcare announced that the company has completed the previously announced acquisition of TheraTears and other over-the-counter consumer brands. This is expected to increase the company’s manufacturing capacity in the U.S. and help in revenue generation
• In September 2021, EUROIMMUN Medizinische Labordiagnostika AG and Immunodiagnostic Systems (IDS) partnership to cooperate in the fields of research and development, production as well as distribution, and this will help to grow the business and generate revenue

Guatemala Specific Pollen Allergies Market Scope

Guatemala specific pollen allergies market is segmented on the basis of drug type, diagnostic test, product, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Type

• Antihistamines
• Decongestants
• Corticosteroids
• Anticholinergics
• Others

Diagnostic Test

• In Vivo Test
• In Vitro Test

Product

• Instruments
• Reagents and Kits
• others

End-User

• Hospitals
• Diagnostics Laboratories
• Academic and Research Institutes
• Others

Distribution Channel

• Direct Tender
• Retail Sales

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The Guatemala specific pollen allergies market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for healthcare analytics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the healthcare analytics market. The data is available for historic period 2015 to 2020.

Competitive Landscape and Specific Pollen Allergies Market Share Analysis

The Guatemala specific pollen allergies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company's focus related to Guatemala specific pollen allergies market.

Some of the major players operating in the Guatemala specific pollen allergies market are:

• Siemens Healthcare GmbH (Germany)
• Sanofi (France)
• bioMérieux SA (France)
• GlaxoSmithKline plc. (U.K.)
• Minaris Medical America, Inc. (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• Circassia (U.K.)
• Alcon Inc. (Switzerland)
• Thermo Fisher Scientific Inc. (U.S.)
• Johnson & Johnson SA de CV (Mexico)
• Lincoln Diagnostics, Inc. (U.S.)
• EUROIMMUN Medizinische Labordiagnostika AG (Germany)
• Bayer Pharmaceuticals (U.S.)
• Prestige Consumer Healthcare Inc. (U.S.)
• CINFA LABORATORIES (Spain)
• Perrigo Company plc. (Ireland)

SKU-69112